In addition, trehalose showed anti-aggregating and molecular chaperone properties in models of proteopathies such as Huntington and Parkinson diseases [21,45] as well as anti-oxidative ones through the activation of the p62-Keap1/Nrf2 pathway [20]. This evidence concerns the gene KEAP1 and Parkinson disease.